ICCM IceCure Medical Ltd

0.9971USD-3.19%Mkt Cap: 4.62M USDP/E: —

IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, …

Key Statistics

Company
Market Cap4.62M USD
Enterprise Value-1.78M USD
Revenue (TTM)3.95M USD
Gross Profit1.23M USD
Net Income (TTM)-15.06M USD
Revenue/Share1.56 USD
Last Price0.9971 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees67
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.36
PEG—
EV/EBITDA0.10
EV/Revenue-0.45
P/S1.18
P/B0.63
EPS (TTM)-7.53 USD
EPS (Forward)-3.31 USD
52W Range
0.65252% of range22.50
52W High22.50 USD
52W Low0.6525 USD
Profitability
Gross Margin36.28%
Oper. Margin-423.69%
EBITDA Margin0.00%
Profit Margin-445.61%
ROE-166.36%
ROA-108.42%
ROIC-3214.09%
ROCE-166.53%
Growth
Revenue Growth72.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-14.57M USD
CapEx (TTM)36.00K USD
FCF Margin-241.65%
FCF Yield-206.23%
Net Debt-11.94M USD
Net Debt/EBITDA0.73
Net Debt/FCF—
Balance Sheet
Debt/Equity0.02
Current Ratio2.88
Quick Ratio2.15
Book Value/Sh3.47 USD
Cash/Share3.51 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:30
Split DateJun 4, 2026
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)22.67 USD
Upside (mean)+2173.3%
Target Range10.00 USD – 30.00 USD
10.00+2173.3% to mean30.00
# Analysts3
Ownership
Shares Out.4.64M
Float2.52M
Insiders68.16%
Institutions11.11%
Short Interest
Short Ratio0.3d
Short % Float1.60%
Short % Out.1.21%
Shares Short56.13K
Short (prev mo.)52.16K
Technical
SMA 501.321 (-24.5%)
SMA 2006.903 (-85.6%)
Beta0.51
S&P 52W Chg12.08%
Avg Vol (30d)210.40K
Avg Vol (10d)163.92K
Technical Indicators
RSI (14)51.1
MACD-0.1076
MACD Signal-0.1675
MACD Hist.+0.0600
BB Upper1.103 USD
BB Middle0.8526 USD
BB Lower0.6022 USD
BB Width58.73%
ATR (14)0.1307 USD
Vol Ratio (20d)1.18x

About IceCure Medical (NASDAQ: ICCM)

›

IceCure Medical (NASDAQ: ICCM) is listed on Nasdaq, where its shares trade in USD. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 67 employees.

The shares were at 0.9971 USD on 19 November 2026, down 95.2% over 52 weeks. Its 52-week range is 0.6525 USD to 22.50 USD: the price is 95.6% below the high and 52.8% above the low.

Its market capitalisation is 4.62M USD.

IceCure Medical reports return on equity of -166.4%, an operating margin of -423.7% and revenue up 72.8% year over year.

It holds more cash than debt, a net cash position of 11.94M USD. Its Piotroski F-score is 4 out of 9, an average reading of its financial health.